Suppr超能文献

利用生物信息学分析鉴定子宫内膜癌中的关键通路和基因。

Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.

作者信息

Liu Yan, Hua Teng, Chi Shuqi, Wang Hongbo

机构信息

Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

出版信息

Oncol Lett. 2019 Jan;17(1):897-906. doi: 10.3892/ol.2018.9667. Epub 2018 Nov 5.

Abstract

Endometrial cancer (EC) is one of the most common gynecological cancer types worldwide. However, to the best of our knowledge, its underlying mechanisms remain unknown. The current study downloaded three mRNA and microRNA (miRNA) datasets of EC and normal tissue samples, GSE17025, GSE63678 and GSE35794, from the Gene Expression Omnibus to identify differentially expressed genes (DEGs) and miRNAs (DEMs) in EC tumor tissues. The DEGs and DEMs were then validated using data from The Cancer Genome Atlas and subjected to gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis. STRING and Cytoscape were used to construct a protein-protein interaction network and the prognostic effects of the hub genes were analyzed. Finally, miRecords was used to predict DEM targets and an miRNA-gene network was constructed. A total of 160 DEGs were identified, of which 51 genes were highly expressed and 100 DEGs were discovered from the PPI network. Three overlapping genes between the DEGs and the DEM targets, BIRC5, CENPF and HJURP, were associated with significantly worse overall survival of patients with EC. A number of DEGs were enriched in cell cycle, human T-lymphotropic virus infection and cancer-associated pathways. A total of 20 DEMs and 29 miRNA gene pairs were identified. In conclusion, the identified DEGs, DEMs and pathways in EC may provide new insights into understanding the underlying molecular mechanisms that facilitate EC tumorigenesis and progression.

摘要

子宫内膜癌(EC)是全球最常见的妇科癌症类型之一。然而,据我们所知,其潜在机制仍不清楚。本研究从基因表达综合数据库下载了三个EC和正常组织样本的mRNA和微小RNA(miRNA)数据集,即GSE17025、GSE63678和GSE35794,以鉴定EC肿瘤组织中差异表达基因(DEGs)和miRNA(DEMs)。然后使用来自癌症基因组图谱的数据对DEGs和DEMs进行验证,并进行基因本体论和京都基因与基因组百科全书通路分析。使用STRING和Cytoscape构建蛋白质-蛋白质相互作用网络,并分析核心基因的预后作用。最后,使用miRecords预测DEM靶标并构建miRNA-基因网络。共鉴定出160个DEGs,其中51个基因高表达,从蛋白质-蛋白质相互作用网络中发现了100个DEGs。DEGs与DEM靶标之间的三个重叠基因,即BIRC5、CENPF和HJURP,与EC患者的总生存期显著较差相关。许多DEGs在细胞周期、人类嗜T淋巴细胞病毒感染和癌症相关通路中富集。共鉴定出20个DEMs和29个miRNA基因对。总之,在EC中鉴定出的DEGs、DEMs和通路可能为理解促进EC发生和进展的潜在分子机制提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce1/6313012/114017bc12eb/ol-17-01-0897-g00.jpg

相似文献

1
Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
Oncol Lett. 2019 Jan;17(1):897-906. doi: 10.3892/ol.2018.9667. Epub 2018 Nov 5.
2
3
Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
Exp Ther Med. 2019 Oct;18(4):2554-2564. doi: 10.3892/etm.2019.7870. Epub 2019 Aug 8.
5
Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
Onco Targets Ther. 2018 Apr 4;11:1861-1869. doi: 10.2147/OTT.S156737. eCollection 2018.
7
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
9
Identification of the Key Genes and Pathways in Esophageal Carcinoma.
Gastroenterol Res Pract. 2016;2016:2968106. doi: 10.1155/2016/2968106. Epub 2016 Oct 12.

引用本文的文献

1
Prognostic and clinicopathological significance of survivin in gynecological cancer.
Oncol Rev. 2024 Dec 2;18:1444008. doi: 10.3389/or.2024.1444008. eCollection 2024.
3
Understanding the Molecular Landscape of Endometriosis: A Bioinformatics Approach to Uncover Signaling Pathways and Hub Genes.
Iran J Pharm Res. 2024 Apr 6;23(1):e144266. doi: 10.5812/ijpr-144266. eCollection 2024 Jan-Dec.
4
Identification of key genes related to heart failure by analysis of expression profiles.
Arch Med Sci. 2021 Mar 10;20(2):517-527. doi: 10.5114/aoms/114896. eCollection 2024.
6
Ontologies and Knowledge Graphs in Oncology Research.
Cancers (Basel). 2022 Apr 10;14(8):1906. doi: 10.3390/cancers14081906.
8
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.
Cancers (Basel). 2021 Mar 6;13(5):1137. doi: 10.3390/cancers13051137.
9
Solid tumours hijack the histone variant network.
Nat Rev Cancer. 2021 Apr;21(4):257-275. doi: 10.1038/s41568-020-00330-0. Epub 2021 Feb 10.
10
Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA.
Cancers (Basel). 2020 Sep 8;12(9):2559. doi: 10.3390/cancers12092559.

本文引用的文献

1
miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
J Exp Clin Cancer Res. 2018 Feb 1;37(1):19. doi: 10.1186/s13046-018-0686-6.
2
Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease.
J Res Med Sci. 2017 Dec 26;22:130. doi: 10.4103/jrms.JRMS_967_16. eCollection 2017.
4
Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.
Front Physiol. 2017 Nov 28;8:947. doi: 10.3389/fphys.2017.00947. eCollection 2017.
5
MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.
Oncotarget. 2017 Oct 10;8(54):93014-93028. doi: 10.18632/oncotarget.21745. eCollection 2017 Nov 3.
8
miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
Cancer Sci. 2017 Dec;108(12):2366-2372. doi: 10.1111/cas.13401. Epub 2017 Oct 12.
9
Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey.
Cancer Sci. 2017 Dec;108(12):2478-2486. doi: 10.1111/cas.13398. Epub 2017 Oct 8.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验